← Search

Data · dataset · 2022

Colorectal cancer interleukin-10 blockade scRNA-seq

Listed in DataCite

Objective: PD-1 checkpoint inhibition and adoptive cellular therapy have limited success in patients with microsatellite stable colorectal cancer liver metastases (CRLM).

Description

We demonstrate that interleukin-10 (IL-10) blockade enhances endogenous T cell and chimeric antigen receptor T (CAR-T) cell anti-tumor function in CRLM slice cultures.Design: We created organotypic slice cultures from human CRLM (n = 38) and tested the anti-tumor effects of a neutralizing antibody against IL-10 (αIL-10).

We evaluated slice cultures with single and multiplex immunohistochemistry, in situ hybridization, single cell RNA sequencing, and time-lapse fluorescent microscopy. In addition, we studied the effects of αIL-10 on carcinoembryonic antigen (CEA)-specific CAR-T cells exogenously administered to both human CRLM slice cultures and a CRLM murine model. Results: There was little effect of PD-1 blockade in CRLM slice cultures.

Read the rest (2 more)

In contrast, αIL-10 generated 1.8-fold increase in T cell-mediated carcinoma cell death, and increased proportion of CD8+ T cells and inflammatory polarization of macrophages. In addition to effects on endogenous immune cells in human CRLM, αIL-10 also rescued murine CAR-T cell proliferation and cytotoxicity from myeloid cell-mediated immunosuppression. In human CRLM slices, αIL-10 dramatically improved CEA-specific CAR-T cell cytotoxicity, generating nearly 70% carcinoma apoptosis across multiple human tumors.

We saw a less dramatic, but similar effect of pretreatment of CAR-T cells with an IL-10 receptor blocking antibody, demonstrating that IL-10 inhibits CAR-T function in the CRLM tumor microenvironment. Conclusion: Neutralizing the effects of IL-10 in human CRLM has therapeutic potential as a stand-alone treatment and to augment the function of adoptively transferred CAR-T cells.

Links

Topics

Stated by source
Basic medicine
Inferred from text
Cancer 75% · Microscopy 75% · RNA sequencing 75% · Sequencing 75% · Single-cell RNA sequencing 65%
Provenance · 1 source records, 13 field assertions
SourceKeyLast seenRaw
DataCite10.5061/dryad.0cfxpnw5414 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · DataCiteconnector:datacite@1.0.0/data/attributes/rightsList
byte_sizesource · DataCiteconnector:datacite@1.0.0
concepts[disease].local:disease:cancerenrichment · DataCitekeyword-concept-rules@1.0.0title+description (75%)
concepts[field].fos:basic-medicinesource · DataCiteconnector:datacite@1.0.0
concepts[modality].local:modality:microscopyenrichment · DataCitekeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:rna-seqenrichment · DataCitekeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · DataCitekeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:single-cell-rna-seqenrichment · DataCitekeyword-concept-rules@1.0.0title+description (65%)
descriptionsource · DataCiteconnector:datacite@1.0.0/data/attributes/descriptions
licensesource · DataCiteconnector:datacite@1.0.0/data/attributes/rightsList
publication_datesource · DataCiteconnector:datacite@1.0.0/data/attributes/dates
titlesource · DataCiteconnector:datacite@1.0.0/data/attributes/titles/0/title
version_labelsource · DataCiteconnector:datacite@1.0.0